Phil Tibbo

Dr. Phil Tibbo is a Professor in the Department of Psychiatry at Dalhousie University and holds the Dr. Paul Janssen Chair in Psychotic Disorders. He serves as Director of the Nova Scotia Early Psychosis Program and Co-Director of the Nova Scotia Psychosis Research Unit. His work focuses on neuroimaging (MRS, DTI), genetics, and non-pharmacological treatments for schizophrenia, alongside developing clinical tools for psychosis management.

Education:

• B.Sc. Honours, Mount Allison University
• B.Med.Sc. and MD, Memorial University of Newfoundland
• FRCPC, University of Alberta
• AHFMR Clinical Research Fellow, University of Alberta

Research Interests: Dr. Tibbo investigates schizophrenia and psychosis through neuroimaging techniques (MRS, DTI), genetics, and clinical interventions. Key areas include early psychosis intervention, cannabis use impacts, and relapse prediction tools. He also contributes to national clinical guidelines for early-phase psychosis care.

Awards:

• 2013 Fellow of the Canadian Psychiatric Association
• 2012 Mental Health Commission of Canada Award
• 2000-2005 REACH Innovation Award

Service & Leadership:

• Chair, Schizophrenia Society of Canada Foundation (2012–present)
• Board Member, Canadian Consortium for Early Intervention in Psychosis (2014–present)
• Past Chair, Royal College of Physicians and Surgeons of Canada Psychiatry Examination Committee (2004–2010)

Labs & Teams: Leads the Nova Scotia Early Psychosis Program and collaborates with the Nova Scotia Psychosis Research Unit, focusing on translational research and clinical innovation.